Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation

Biochemical and Biophysical Research Communications

Volumn 364, Issue 4, 2007, Pages 790-795

  Ishima, Yu ^a   Akaike, Takaaki ^b   Kragh Hansen, Ulrich ^c   Hiroyama, Shuichi ^a   Sawa, Tomohiro ^b   Maruyama, Toru ^a   Kai, Toshiya ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Bilirubin; Copper; Cysteine; Fatty acids; Human serum albumin; Ligand binding; Metabolic syndrome; Nitric oxide; S Nitrosylation; Type II diabetes

Indexed keywords

ASCORBIC ACID; BILIRUBIN; COPPER ION; FATTY ACID; HUMAN SERUM ALBUMIN; IRON; NITRIC OXIDE; NITRIC OXIDE DONOR; PROGESTERONE; S NITROSOGLUTATHIONE; TRYPTOPHAN; ZINC ION;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; METABOLIC SYNDROME X; MOUSE; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; HUMANS; HYDRAZINES; LIGANDS; MICE; MODELS, MOLECULAR; MONOCYTES; NITROSO COMPOUNDS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; SERUM ALBUMIN;

EID: 36048931836     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.094     Document Type: Article

References (20)

1. Ignarro L.J., Kadowitz P.J., and Baricos W.H. Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site -SH groups and both substrate and activator. Arch. Biochem. Biophys. 208 (1981) 75-86
2. Ignarro L.J., Lippton H., Edwards J.C., Baricos W.H., Hyman A.L., Kadowitz P.J., and Gruetter C.A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218 (1981) 739-749
3. Ignarro L.J., Barry B.K., Gruetter D.Y., Edwards J.C., Ohlstein E.H., Gruetter C.A., and Baricos W.H. Guanylate cyclase activation of nitroprusside and nitrosoguanidine is related to formation of S-nitrosothiol intermediates. Biochem. Biophys. Res. Commun. 94 (1980) 93-100
4. Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. Free. Radic. Biol. Med. 28 (2000) 1478-1486
5. Foster M.W., McMahon T.J., and Stamler J.S. S-Nitrosylation in health and disease. Trends Mol. Med. 9 (2003) 160-168
6. Stamler J.S., Simon D.I., Osborne J.A., Mullins M.E., Jaraki O., Michel T., Singel D.J., and Loscalzo J. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA 89 (1992) 444-448
7. Hallstrom S., Gasser H., Neumayer C., Fugl A., Nanobashvili J., Jakubowski A., Huk I., Schlag G., and Malinski T. S-Nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 105 (2002) 3032-3038
8. Dworschak M., Franz M., Hallstrom S., Semsroth S., Gasser H., Haisjackl M., Podesser B.K., and Malinski T. S-Nitroso human serum albumin improves oxygen metabolism during reperfusion after severe myocardial ischemia. Pharmacology 72 (2004) 106-112
9. Ishima Y., Sawa T., Kragh-Hansen U., Miyamoto Y., Matsushita S., Akaike T., and Otagiri M. S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial and cytoprotective properties. J. Pharmacol. Exp. Ther. 320 (2007) 969-977
10. Peters Jr. T. All About Albumin: Biochemistry, Genetics, and Medical Applications (1996), Academic Press, San Diego
11. Chen R.F. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242 (1967) 173-181
12. Gryzunov Y.A., Arroyo A., Vigne J.L., Zhao Q., Tyurin V.A., Hubel C.A., Gandley R.E., Vladimirov Y.A., Taylor R.N., and Kagan V.E. Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. Arch. Biochem. Biophys. 413 (2003) 53-66
13. Akaike T., Inoue K., Okamoto T., Nishino H., Otagiri M., Fujii S., and Maeda H. Nanomolar quantification and identification of various nitrosothiols by high performance liquid chromatography coupled with flow reactors of metals and Griess reagent. J. Biochem. (Tokyo) 122 (1997) 459-466
14. Ikebe N., Akaike T., Miyamoto Y., Hayashida K., Yoshitake J., Ogawa M., and Maeda H. Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury. J. Pharmacol. Exp. Ther. 295 (2000) 904-911
15. Inoue K., Akaike T., Miyamoto Y., Okamoto T., Sawa T., Otagiri M., Suzuki S., Yoshimura T., and Maeda H. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J. Biol. Chem. 274 (1999) 27069-27075
16. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33 (1981) 17-53
17. Petitpas I., Grune T., Bhattacharya A.A., and Curry S. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 314 (2001) 955-960
18. Zhang Y., and Wilcox D.E. Thermodynamic and spectroscopic study of Cu(II) and Ni(II) binding to bovine serum albumin. J. Biol. Inorg. Chem. 7 (2002) 327-337
19. Stubauer G., Giuffre A., and Sarti P. Mechanism of S-nitrosothiol formation and degradation mediated by copper ions. J. Biol. Chem. 274 (1999) 28128-28133
20. Miyamoto Y., Akaike T., Alam M.S., Inoue K., Hamamoto T., Ikebe N., Yoshitake J., Okamoto T., and Maeda H. Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity. Biochem. Biophys. Res. Commun. 267 (2000) 918-923